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Abstract
Background: Dengue is an acute febrile illness considered the major arboviral disease in terms of morbidity, mortality,
economic impact and dissemination worldwide. Brazil accounts for the highest notification rate, with circulation of all
four dengue serotypes. The NS1 antigen is a dengue highly conserved specific soluble glycoprotein essential for viral
replication and viability that can be detected 0 to 18 days from the onset of fever (peak first 3 days). It induces a strong
humoral response and is known as a complement-fixing antigen. Lower NS1 test sensitivity occurs in secondary
dengue infections probably due to immune complex formation impairing antigen detection by ELISA.
Methods: We compared the sensitivity of NS1 ELISA in heat dissociated and non-dissociated samples from 156 RT-PCR
confirmed acute dengue-4 cases from 362 prospectively enrolled patients.
Results: Secondary infections accounted for 83.3% of cases. NS1 ELISA was positive in 42.5% and indeterminate in 10.
2% of dengue-4 cases. After heat dissociation, 7 negative and 16 indeterminate samples turned positive, increasing the
overall test sensitivity to 57.7%.
Conclusions: Although it is time consuming and requires the use of specific laboratory equipment, NS1 ELISA
combined with heat dissociation could be a slightly better alternative for triage in suspected dengue cases.
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Background
Dengue is an acute febrile illness considered the major
worldwide arboviral disease, in terms of morbidity,
mortality, economic impact and dissemination [1].
Dengue occurs in all non-polar continents [2] and is an
important public health concern in tropical and subtro-
pical regions mainly in Asia and Americas [3, 4]. Estimates
account for 390 million dengue infections per year of
which 96 million present clinical manifestations [5]. The
disease is endemic in 100 countries and approximately
40% of the world population is at risk of dengue infection
[1]. By the end of the 20th century, Brazil became the
country with the highest notification rate, accounting for
98.5% of the American continent’s reported cases and the
highest fatality rate in the sub region [1]. Since 2008, all
four dengue serotypes (DENV-1 to DENV-4) can be found
in the country [6].
NS1 Ag is a dengue highly conserved specific soluble
glycoprotein essential for viral replication and viability
that can be detected in dengue patients from day 1 up to
18 days after fever onset [7] with peak sensitivity in the
first 3 days of fever onset [8]. It induces a strong
humoral response and is known as a complement-fixing
antigen [9].
Previous studies have evaluated the usefulness and the
accuracy NS1 tests [10–14]. According to da Costa et al.
the main factors influencing the diagnostic accuracy are
the type of infection (primary versus secondary), viral
serotype, geographical origins of samples, and the timing
of sample collection [12].
Low NS1 test sensitivity in secondary dengue infections
may be attributed to high levels of IgG in anamnestic
response with immune complex formation impairing anti-
gen detection by ELISA [9, 15]. Some studies have also
noticed lower NS1 sensitivity in DENV-4 compared to
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other serotypes, in both primary and secondary dengue
[12, 13]. Furthermore, immune complex dissociation tech-
niques have proven to be important for the early diagnosis
of HIV infections and most recently DENV [9, 16]. A
study conducted in Rio de Janeiro with DENV-4 cases an-
alyzed acid treatment/neutralization and heat dissociation,
with a better performance for the latter [9]. In the present
study, we compared the sensitivity of NS1 ELISA in heat
dissociated and non-dissociated samples from acute
DENV-4 patients.
Methods
This study is part of a prospective cross-sectional
pragmatic diagnostic study of clinical and diagnostic
algorithms for dengue diagnosis conducted at Rio de
Janeiro, Brazil during the 2013 dengue epidemic
season (March and April). We used the Standards for
Reporting of Diagnostic Accuracy Study (STARD)
Guideline [17]. Eligible adult patients who presented
to a public outpatient unit (Unidade de Pronto
Atendimento-UPA 24H) within 72 h of a febrile
illness without an evident source of infection were
interviewed and examined by the investigators. At the
time the study was carried out there were no
evidences that other Flaviviruses, such as Zika were
circulating in Rio de Janeiro [18].
Blood samples were collected and sera stored at
-70 °C until the tests. The index test (Platelia™ Den-
gue NS1 Ag-ELISA), specific IgG and confirmatory
RT-PCR were all performed at the Flavivirus Regional
Reference Laboratory, IOC, FIOCRUZ.
The Platelia™ Dengue NS1 Ag-ELISA (Bio-Rad Labora-
tories, Marnes-La-Coquette, France) was performed in
all samples according to the manufacturer’s instructions
and described elsewhere, briefly the test is based on a
one-step sandwich format microplate enzyme
Fig. 1 STARD [17] diagram DENV-4 patients in Rio de Janeiro, 2013
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immunoassay to detect DENV NS1 antigen in human
serum [10].
The same samples were further submitted to the
heat dissociation method when 50 μL of the serum
was added to 100 μL of RNA/DNAse free water and
heated in a boiling water bath for five minutes, as de-
scribed previously [9].
We defined as secondary cases those patients who
presented positive IgG results within 72 h onset of
disease [19]. The Dengue Virus IgG DxSelect™ ELISA
(Focus Diagnostics, California, USA) was performed
according to the manufacturer’s instructions in all
samples to diagnose secondary dengue cases.
The viral RNA detection by RT-PCR was performed ac-
cording to the technique described elsewhere [20]. Labora-
tory personnel were blinded to other laboratory data such as
Platelia™ Dengue NS1 Ag-ELISA, IgG and RT-PCR when
executing a specific test. DENV infections by other serotypes
were excluded. Exploratory analysis was performed using
SPSS© v 17.0 (SPSS Inc., Chicago, Illinois). The MedCalc©
14.8.1 program was used to calculate 95% confidence inter-
vals (CI) for the Platelia™ Dengue NS1 Ag-ELISA sensitivity.
Results
A total of 372 ambulatory patients were enrolled, with
10 exclusions (six presenting symptoms for more than
3 days and four due to infections to other DENV
serotypes. The remaining 362 patients had their clinical
profile previously described [21]. Briefly, 55.6% were
female, the median age was 33 years old (ranging from
18 to 83) and the median time from the onset of illness
was two days.
The RT-PCR identified DENV-4 in 42.8% (156/362) of
the cases. From those, 16.7% (26/156) were classified as
primary infection cases and 83.3% (129/156), as second-
ary ones, Fig. 1.
The NS1 ELISA performance as described by the man-
ufacturer’s protocol in the 156 DENV-4 cases resulted in
43.0% (67/156) of positive cases, 46.8% (73/156) negative
and 10.2% (16/156) indeterminate (Table 1). After the
heat dissociation process, all 67 DENV-4 positive cases
remained positive; 7 negative all 16 indeterminate cases
became positive, as also described by Lima et al [9].
These results could jeopardize the theory of IgG im-
mune complex formation; however the increase in sensi-
tivity in those cases might occur due to an increased
detection of monomeric NS1 forms [22].
Discussion
In our study, the overall sensitivity of the NS1 test in
DENV-4 cases was 47.8%, quite similar to the 46.6% ob-
tained by Lima [9], but lower than the 58% sensitivity
obtained in da Costa’s meta-analysis [12], Table 2. This
low overall sensitivity may be caused by the South
American virus polymorphism lower overall viremia and
lower NS1 secretion [12, 13]. The differences in the sen-
sitivities in primary and secondary infections in our case
before heat dissociation 80.9% vs 42.0% were also found
in da Costa’s meta-analysis (94.6% vs 66%) [12]. Even at-
tenuating the influence of secondary infections by heat
dissociation, the sensitivities obtained were still low.
Table 1 DENV-4 NS1 performance according to type of







































Table 2 Sensitivity of Platelia™ Dengue NS1 Ag-ELISA in acute DENV-4, Rio de Janeiro, 2013
Platelia™ Dengue NS1 Ag-ELISA Sensitivity
(95% CI)
p-value















Buonora et al. BMC Infectious Diseases  (2017) 17:204 Page 3 of 5
We demonstrated significant sensitivity increases after
dissociation in both types of DENV-4 infections in
agreement with other studies that used unspecific
dengue serotype acid dissociated NS1 samples [15, 23].
This study has advantages since it was prospectively
executed, the samples were clinically and laboratorially
well characterized, and collected during a single out-
break in one outpatient unit increasing the chance of
genotypic similarity, quite different from the previous
study which was carried out during a 17 month period
when genotypic heterogeneity is possible [9]. We were
able to demonstrate the advantages of incorporating heat
dissociation to the Platelia™ Dengue NS1 Ag-ELISA kit
in order to increase its sensitivity, mostly in settings
where circulating DENV-4 can be an issue. The study
limitation was the lack of heterogeneity of viral strains
that impairs the generalization of the results in other
epidemic settings.
Conclusions
Although time expending and the requirement of spe-
cific laboratory equipment the NS1 ELISA combined to
heat dissociation could be a slightly better alternative for
accurate dengue diagnosis.
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